To assess safety and tolerability of ALV003 in healthy volunteers and patients with Celiac Disease
A Phase 1, Two Stage, Single Dose, Single-Blind, Placebo Controlled, Dose Escalation, Crossover Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
28
4 dose levels of ALV003 vs placebo
Clinical Applications Laboratories Inc.
San Diego, California, United States
safety and tolerability
Time frame: Throughout
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.